Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.980
-0.060 (-2.94%)
At close: Oct 3, 2025, 4:00 PM EDT
1.990
+0.010 (0.51%)
After-hours: Oct 3, 2025, 7:38 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $134.17 million as of October 3, 2025. Its market cap has decreased by -74.93% in one year.
Market Cap
134.17M
Enterprise Value
-52.59M
1-Year Change
-74.93%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $134.17M, a decrease of -66.72%. That is a compound annual growth rate of -23.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 134.17M | 10.88% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.01B |
| Johnson & Johnson | 447.90B |
| AbbVie | 417.90B |
| UnitedHealth Group | 320.35B |
| AstraZeneca | 259.06B |
| Novo Nordisk | 258.32B |
| Novartis AG | 251.99B |
| Abbott Laboratories | 231.46B |